Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish, page-3

  1. 2,356 Posts.
    lightbulb Created with Sketch.  13
    seriously ......................."Apart from $47 million in cash and an additional $75-million non-dilutive credit facility, Mesoblast will likely need additional capital to finance its late-stage development, the analyst said."

    I think we have moved on from this issue.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.